Fundraising Fox
🦊/Companies
Sign in

Pandorum Technologies

7 known investors

Find your way into Pandorum Technologies

252 people in our graph share verified history with the Pandorum Technologies team — schools, employers, funds. One of them is your warm intro.

Marcunlockedknows Tuhin Bhowmick · together at Massachusetts Institute of Technology (overlapped)
×4knows the team · via Massachusetts Institute of Technology
×2knows the team · via Indian Institute of Science
×4knows the team · via EMBL
knows the team · via The Maharaja Sayajirao University of Baroda

Pandorum Technology develops tissue engineering and regenerative medicine products using proprietary stem cell and exosome platforms to address corneal dystrophies, lung disorders, and liver diseases. The company creates bio-engineered functional tissues through cell engineering, 3D printing, and cell-free therapies for medical research and therapeutic applications.

BiotechDeep TechMedical Devices

Founders & leadership

AC
Arun Chandru
TBTuhin Bhowmick
Tuhin BhowmickinTuhin Bhowmick is the founder of Pandorum Technologies, a tissue engineering and regenerative medicine company developing stem cell and exosome platforms for corneal, pulmonary, and hepatic disorders. His background spans research in tissue engineering, biomaterials, and cellular reprogramming.
KG
K.P. Goankar
B
BhartiAssistant Research Scientist - Optometry
H
HariManager - Operations
S
SuvroResearch Scientist

Investors · 7

500 GlobalSan Francisco · $150K
Xeed VenturesBengaluru · $120K – $1.2M

Also in the syndicate · 5

Avinya FundGalentic PharmaGalentic Pharma (India) Pvt. Ltd.Noblevast AdvisoryProtons Corporatelead

Funding

SEC filings, press & company announcements

$18 disclosed across 1 of 3 rounds · 2026

  • Undisclosed amountSeries BAug 2026

    Protons Corporate (lead), Avinya Fund, Galentic Pharma, Noblevast Advisory

    Source ↗
  • Undisclosed amountSeries BApr 2026

    Protons Corporate (lead), Avinya Fund, Galentic Pharma, Noblevast Advisory

    Source ↗
  • $18Series BFeb 2026 · 2 sources

    Protons Corporate (lead), Avinya Fund, Galentic Pharma, Galentic Pharma (India) Pvt. Ltd., Noblevast Advisory

    Source ↗

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Pharma Funding Roundup: QuantX Biosciences, Pandorum Technologies Complete Series B Financing Rounds | PharmExecpharmexec.com · Aug 2026Pandorum Technologies Raises $18 Million in Series B Funding | Medical Product Outsourcingmpo-mag.com · Apr 2026Yourstoryyourstory.com · Feb 2026Pandorum Technologies Raises USD 18 Mn in Series B Funding Led by Protons Corporateindia.entrepreneur.com · Feb 2026Pandorum Technologies Raises US$18 Million in Series B to Advance Global Access to Programmable Tissue Regenerative Therapiesbusinesswire.com · Feb 2026BBC-Incubated Startup Pandorum Technologies Raises $18 Million in Series B Funding | Bangalore Bioinnovation Centrebioinnovationcentre.com · Feb 2026

Frequently asked questions

What does Pandorum Technologies do?
Pandorum Technology develops tissue engineering and regenerative medicine products using proprietary stem cell and exosome platforms to address corneal dystrophies, lung disorders, and liver diseases. The company creates bio-engineered functional tissues through cell engineering, 3D printing, and cell-free therapies for medical research and therapeutic applications.
Who founded Pandorum Technologies?
Pandorum Technologies was founded by Arun Chandru, Tuhin Bhowmick.
Who are Pandorum Technologies's investors?
Pandorum Technologies's investors include 500 Global, Xeed Ventures.
How much funding has Pandorum Technologies raised?
Pandorum Technologies has disclosed $18 raised across 1 of its 3 known rounds.